News from CEPTON Strategies

News and publications

Discover our latest publications and the press articles

CEPTON is a renowned strategy consulting firm in its areas of expertise such as Pharma, Medtech & Healthcare Services. Being both authors and subjects of various publications in our partners’ fields of expertise, CEPTON is often covered by the specialized press.

AI in drug discovery: will tomorrow’s New Molecule Entities be discovered by robots?

Posted on 02.09.2019 by Maxime Huerre

See more

The growing role of Real-World Evidence, from regulatory strategies to patient management

Posted on 30.04.2019 by Maxime Huerre

See more

Forever young: how the cult of beauty created a $11bn medical aesthetics market

Posted on 22.01.2019 by Maxime Huerre

See more

CEPTON ranked among the top consulting firms in Healthcare and Pharma Industry by the magazine "Les Décideurs"

Posted on 21.01.2019 by Maxime Huerre

See more

Radiopharmaceuticals: the crucial role of production and supply chain

Posted on 02.11.2018 by Marc-Olivier Bévierre

See more

Strategic Alliances: the right prescription to survive the Healthcare Revolution

Posted on 02.11.2018 by Marc-Olivier Bévierre

See more

Radiopharmaceuticals: a powerful tool for precision medicine

Posted on 17.09.2018 by Marc-Olivier Bévierre

See more

CAR-Ts: an exciting challenge for European healthcare systems

Posted on 03.09.2018 by Marc-Olivier Bévierre

See more

The immunotherapy revolution: Checkpoint inhibitors

Posted on 28.08.2018 by Marc-Olivier Bévierre

See more

The human microbiome: an emerging industry

Posted on 27.07.2018 by Marc-Olivier Bévierre

See more

The Human microbiome: a burning research field with multiple applications

Posted on 15.07.2018 by Marc-Olivier Bévierre

See more

Telemedicine: the future we already have

Posted on 15.06.2018 by Marc-Olivier Bévierre

See more

Gene therapy 2.0: How will gene editing help overcome gene therapy limitations?

Posted on 02.01.2018 by Marc-Olivier Bévierre

See more

Why Managed Access Programs should be a key component of your strategy for Europe

Posted on 14.12.2017 by Marc-Olivier Bévierre

See more

11 things innovative healthcare firms must know when planning to launch in Europe

Posted on 07.12.2017 by Marc-Olivier Bévierre

See more

The future of IVDs: important regulatory changes will soon redistribute the cards in the EU

Posted on 01.12.2017 by Marc-Olivier Bévierre

See more

European reform: the changes to expect for class IIb and class III medical devices

Posted on 27.11.2017 by Marc-Olivier Bévierre

See more

How will Brexit affect the strategies of US biotechs?

Posted on 20.11.2017 by Marc-Olivier Bévierre

See more

European biosimilar market: a tremendous opportunity with variable market access constraints

Posted on 14.11.2017 by Marc-Olivier Bévierre

See more

Gene therapy: the trap of biomanufacturing

Posted on 07.10.2017 by Marc-Olivier Bévierre

See more

CEPTON ranks among the best consulting firms in France in categories "Strategy" and "Healthcare".

Posted on 16.10.2016 by CEPTON Strategies

The CEPTON team is proud to announce that, after only 10 years of existence, CEPTON has already been ranked among the best consulting firms in both categories "Strategy" and "Healthcare".
See more

Philippe COCUDE joins CEPTON

Posted on 17.06.2014 by CEPTON Strategies

We have the pleasure to announce that Philippe Cocude joins CEPTON as a new partner in the Paris office.
See more

Towards a more integrated approach of patient care (Le Monde)

Posted on 28.03.2014 by CEPTON Strategies

The French National Health Service is looking for more quality, but also more efficiency in the delivery of care.
See more

CEPTON supports the development of biotech in France

Posted on 11.03.2014 by CEPTON Strategies

Biotech/Medtech companies are a major source of value and job creation in France.
See more

Hepatitis C: the future landscape

Posted on 09.12.2012 by CEPTON Strategies

New, breakthrough treatments of Hepatitis C are emerging, which are considerably more effective and lead to complete remission in more than 90% of cases.
See more

Molecular diagnostics: market dynamics and future developments

Posted on 07.06.2012 by CEPTON Strategies

Colloque France Biotech, le 7 juin 2012. Molecular diagnostics is the key to personalized medicine. In that respect, it has a promising future.
See more

The Revolution of personalized medicine

Posted on 08.11.2011 by CEPTON Strategies

From risk profiling to gene therapy and molecular diagnostics, personalized medicine opens new, exciting fields to medical research.
See more